Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug June 10, 2021 Auto Bot Aduhelm (Drug), alzheimer's disease, Biogen Inc, Clinical Trials, elderly, your-feed-science 0 The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients.